Glycemic control and survival in peritoneal dialysis patients with diabetes mellitus.

International Urology and Nephrology
Nigar SekerciogluJoanne M Bargman

Abstract

The optimal target for glycated hemoglobin (HbA1c) has not been well defined in peritoneal dialysis (PD) patients with diabetes mellitus. The objective of our study was to examine the predictive value of predialysis and time-averaged follow-up HbA1c values on technique and patient survival in diabetic PD patients treated in the Toronto General Hospital Home Peritoneal Dialysis Unit, between January 1, 2003 and December 31, 2008 with a median follow-up period of 30±23 months. Ninety-one patients (mean age 64±13 years-old) were included in this retrospective study. Patients were followed between 3 and 91 months (mean duration 30±23 months). During this period, 40 patients died. We found no statistically significant correlation between baseline predialysis HbA1c values and technique and patient survival. Time-averaged follow-up HbA1c in increments<6.5%, 6.5-8%, and >8% showed no significant survival difference among groups. There was no significant correlation of baseline and time-averaged follow-up HbA1c values with patient and PD technique survival.

References

Oct 1, 1993·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·A H TzamaloukasP S Avasthi
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
Jan 1, 1995·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Y Suzuki, M Arakawa
Nov 14, 1997·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·M S WuM L Leu
Aug 30, 2002·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Stephen D McMurrayKathryn McDougall
Oct 7, 2005·Journal of the American Society of Nephrology : JASN·Vandana MenonMark J Sarnak
Feb 3, 2007·Journal of the American Society of Nephrology : JASN·Masaaki InabaUNKNOWN Osaka CKD Expert Research Group
Feb 6, 2007·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·UNKNOWN KDOQI
Mar 6, 2007·Diabetes Care·Kamyar Kalantar-ZadehKumar Sharma
Mar 28, 2007·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Cheuk-Chun SzetoPhilip Kam-Tao Li
Jun 10, 2008·The New England Journal of Medicine·Anushka PatelFlorence Travert
Jun 10, 2008·The New England Journal of Medicine·UNKNOWN Action to Control Cardiovascular Risk in Diabetes Study GroupWilliam T Friedewald
Dec 2, 2009·Circulation·Christiane DrechslerChristoph Wanner
Jan 9, 2010·Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis·Barry I FreedmanAnthony J Bleyer
Mar 30, 2010·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Sabin ShurrawUNKNOWN Alberta Kidney Disease Network
Nov 13, 2010·American Journal of Nephrology·Kuan-Hsing ChenCheng-Chieh Hung
Feb 4, 2011·The American Journal of the Medical Sciences·Kuan-Hsing ChenChih-Wei Yang
Apr 23, 2011·Clinical Journal of the American Society of Nephrology : CJASN·Uyen DuongKamyar Kalantar-Zadeh

❮ Previous
Next ❯

Citations

Jan 29, 2014·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Marijn SpeeckaertUNKNOWN European Renal Best Practice Guideline Development Group on Diabetes in Advanced CKD
Jan 16, 2016·The Korean Journal of Internal Medicine·Jong-Hak LeeYong-Lim Kim
Aug 21, 2013·Journal of the American Society of Nephrology : JASN·Philip K T LiUNKNOWN IMPENDIA and EDEN Study Groups
Nov 15, 2014·Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis·Fenfen PengXueqing Yu
Jul 3, 2021·Journal of Clinical Medicine·Juan M BuadesNicanor Vega

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Guntram SchernthanerGerit-Holger Schernthaner
Clinical Journal of the American Society of Nephrology : CJASN
Uyen DuongKamyar Kalantar-Zadeh
© 2021 Meta ULC. All rights reserved